Literature DB >> 21916580

Implication of miRNA in the diagnosis and treatment of breast cancer.

Carlos A Castañeda1, María Teresa Agullo-Ortuño, Juan Angel Fresno Vara, Hernan Cortes-Funes, Henry L Gomez, Eva Ciruelos.   

Abstract

Breast cancer (BC) comprises a group of different diseases characterized by changes in tissue structure and gene expression. Recent advances in molecular biology have shed new light on the participation of genes and their products in the biology of BC. MicroRNAs (miRNAs) are small noncoding endogenous RNA molecules that appear to modulate the expression of more than a third of human genes, and their implications in cancer have grasped the attention of the scientific community. Recently, several studies have described the association between miRNA expression profiles and pathological and clinical BC features. Moreover, these molecules represent a new type of molecular marker that can identify prognosis and guide the management of BC patients. With the increasing understanding of miRNA networks and their impact in the biology of BC, as well as the development of viable strategies to modulate specific miRNAs, we could improve the treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21916580     DOI: 10.1586/era.11.40

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  6 in total

1.  MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer.

Authors:  Lei Huo; Yan Wang; Yun Gong; Savitri Krishnamurthy; Jing Wang; Lixia Diao; Chang-Gong Liu; Xiuping Liu; Feng Lin; William F Symmans; Wei Wei; Xinna Zhang; Li Sun; Ricardo H Alvarez; Naoto T Ueno; Tamer M Fouad; Kenichi Harano; Bisrat G Debeb; Yun Wu; James Reuben; Massimo Cristofanilli; Zhuang Zuo
Journal:  Mod Pathol       Date:  2016-02-26       Impact factor: 7.842

2.  Regulation of the microRNA 200b (miRNA-200b) by transcriptional regulators PEA3 and ELK-1 protein affects expression of Pin1 protein to control anoikis.

Authors:  Xusen Zhang; Bailin Zhang; Jidong Gao; Xiang Wang; Zhihua Liu
Journal:  J Biol Chem       Date:  2013-09-26       Impact factor: 5.157

3.  The effects of low-level laser irradiation on breast tumor in mice and the expression of Let-7a, miR-155, miR-21, miR125, and miR376b.

Authors:  Vahid Khori; Ali Mohammad Alizadeh; Zohre Gheisary; Sadaf Farsinejad; Farrokh Najafi; Solmaz Khalighfard; Fatemeh Ghafari; Maryam Hadji; Hamid Khodayari
Journal:  Lasers Med Sci       Date:  2016-08-12       Impact factor: 3.161

4.  Genome-wide screen for aberrantly expressed miRNAs reveals miRNA profile signature in breast cancer.

Authors:  Li Guo; Yang Zhao; Sheng Yang; Min Cai; Qian Wu; Feng Chen
Journal:  Mol Biol Rep       Date:  2012-11-30       Impact factor: 2.316

5.  MiRNA-107 enhances the malignant progression of pancreatic cancer by targeting TGFBR3.

Authors:  Tingke Tian; Quanzhong Yang; Cuijuan Zhang; Xiaokun Li; Jiancheng Cheng
Journal:  PLoS One       Date:  2021-05-19       Impact factor: 3.240

Review 6.  Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases.

Authors:  Katerin Rojas Laimito; Angelo Gámez-Pozo; Juan Sepúlveda; Luis Manso; Rocío López-Vacas; Tomás Pascual; Juan A Fresno Vara; Eva Ciruelos
Journal:  Ecancermedicalscience       Date:  2016-04-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.